Ibrahim M. Ibrahim
- Molecular Biology
- Pharmaceutical Science top 5%
- Biomaterials
- Infectious Diseases
- Biomedical Engineering
- Co-authors
- Gul ShahnazAbbas RahdarTanveer A. TabishSadanand PandeyMaria Hassan KianiShahid KarimRabia ArshadMisook Kang
- Topics
- Drug Transport and Resistance Mechanisms (3 papers)COVID-19 Clinical Research Studies (3 papers)Nanoparticle-Based Drug Delivery (3 papers)
- Partner nations
- Saudi ArabiaIndiaIran
In The Last Decade
Ibrahim M. Ibrahim
25 papers receiving 406 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 104
- Pharmaceutical Science 90
- Biomaterials 90
- Infectious Diseases 47
- Biomedical Engineering 44
Countries citing papers authored by Ibrahim M. Ibrahim
This map shows the geographic impact of Ibrahim M. Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim M. Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim M. Ibrahim more than expected).
Fields of papers citing papers by Ibrahim M. Ibrahim
This network shows the impact of papers produced by Ibrahim M. Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim M. Ibrahim. The network helps show where Ibrahim M. Ibrahim may publish in the future.
Co-authorship network of co-authors of Ibrahim M. Ibrahim
This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim M. Ibrahim. A scholar is included among the top collaborators of Ibrahim M. Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim M. Ibrahim. Ibrahim M. Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 1 | |
| 4 | 28 | |
| 5 | 6 | |
| 6 | 12 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 20 | |
| 10 | 3 | |
| 11 | 7 | |
| 12 | 28 | |
| 13 | 59 | |
| 14 | 20 | |
| 15 | 22 | |
| 16 | 8 | |
| 17 | 27 | |
| 18 | 18 | |
| 19 | 28 | |
| 20 | 15 |
About Ibrahim M. Ibrahim
Ibrahim M. Ibrahim is a scholar working on Toxicology, Geriatrics and Gerontology and Pharmaceutical Science, having authored 25 papers that have together received 413 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), COVID-19 Clinical Research Studies (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Pharmaceutical Science (90 citations), Toxicology (35 citations) and Biomaterials (90 citations). Ibrahim M. Ibrahim has collaborated with scholars based in Saudi Arabia, India and Iran. Frequent co-authors include Gul Shahnaz, Abbas Rahdar, Tanveer A. Tabish, Sadanand Pandey, Maria Hassan Kiani, Shahid Karim, Rabia Arshad, Misook Kang, Ahmed S. Ali and Aditya N. Bade. Their work appears in journals such as Biomaterials, International Journal of Molecular Sciences and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.